Meenhard Herlyn studied melanoma for 20 years before he ever met a single patient with the disease. He has published more than 380 papers on melanoma and other cancers, in which he discovered monoclonal antibodies to tumor cells that are still used to diagnose some types of cancer, characterized stages in melanoma's progression, and identified genes that play key roles in that progression.
Survey Series
For Advertisers
A life behind life science
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.